How big is the Glycobiology Market?

The Glycobiology Market size is expected to reach USD 0.62 billion in 2024 and grow at a CAGR of 14.87% to reach USD 1.24 billion by 2029. Read More

What is the current Glycobiology Market size?

In 2024, the Glycobiology Market size is expected to reach USD 0.62 billion. Read More

Who are the key players in Glycobiology Market?

Agilent Technologies, Waters Corporation, Shimadzu Corporation, Merck KGaA and New England Biolabs are the major companies operating in the Glycobiology Market. Read More

Which is the fastest growing region in Glycobiology Market?

Europe is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Glycobiology Market?

In 2024, the North America accounts for the largest market share in Glycobiology Market. Read More

What years does this Glycobiology Market cover, and what was the market size in 2023?

In 2023, the Glycobiology Market size was estimated at USD 0.54 billion. The report covers the Glycobiology Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Glycobiology Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Glycobiology Market Share

Statistics for the 2023 & 2024 Glycobiology market share, created by Mordor Intelligence™ Industry Reports. Glycobiology share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Glycobiology Industry

The glycobiology market is moderately competitive, with the presence of a considerable number of companies that significantly contribute to the market growth. New product launches, mergers and acquisitions, partnerships, and collaborations are the key strategies adopted by these companies for sustainable growth. Some key companies in the market include Agilent Technologies, Waters Corporation, Shimadzu Corporation, Merck KGaA, and New England Biolabs, among others.